Bristol Myers Squibb Co.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US1101221083
USD
56.48
0.91 (1.64%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jul'25
Jun'25
Mar'25
Dec'24
Net Sales
11,489.00
12,502.00
12,222.00
12,222.00
12,269.00
11,201.00
12,342.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
11,489.00
12,502.00
12,222.00
12,222.00
12,269.00
11,201.00
12,342.00
Raw Material Cost
3,873.00
4,221.00
4,156.00
3,313.00
4,199.00
3,861.00
4,918.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
411.00
432.00
480.00
480.00
485.00
494.00
496.00
Selling and Distribution Expenses
1,617.00
2,088.00
1,788.00
1,788.00
1,691.00
1,583.00
2,105.00
Other Expenses
182.70
212.90
195.30
195.30
177.70
174.20
229.20
Total Expenditure (Excl Depreciation)
7,728.00
8,870.00
8,377.00
7,534.00
8,152.00
7,680.00
9,811.00
Operating Profit (PBDIT) excl Other Income
3761
3632
3845
4688
4117
3521
2531
Other Income
357.00
737.00
827.00
865.00
779.00
466.00
580.00
Operating Profit (PBDIT)
4,729.00
5,401.00
5,698.00
4,722.00
5,925.00
5,015.00
4,980.00
Interest
411.00
432.00
480.00
480.00
485.00
494.00
496.00
Exceptional Items
-468.00
-2,467.00
-1,078.00
-1,127.00
-2,638.00
-523.00
-2,440.00
Gross Profit (PBDT)
7,616.00
8,281.00
8,066.00
8,909.00
8,070.00
7,340.00
7,424.00
Depreciation
611.00
1,032.00
1,026.00
0.00
1,029.00
1,028.00
1,869.00
Profit Before Tax
3,239.00
1,470.00
3,114.00
3,114.00
1,773.00
2,971.00
175.00
Tax
561.00
384.00
919.00
919.00
460.00
509.00
99.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,677.00
1,087.00
2,201.00
2,201.00
1,310.00
2,456.00
72.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,677.00
1,087.00
2,201.00
2,201.00
1,310.00
2,456.00
72.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.00
-1.00
-6.00
-6.00
3.00
6.00
4.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,678.00
1,086.00
2,195.00
2,195.00
1,313.00
2,462.00
76.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.1
0.1
0.1
0.0
0.1
0.1
0.1
Reserves
20,068.00
18,473.00
18,552.00
0.00
17,436.00
17,389.00
16,335.00
Earnings per share (EPS)
1.31
0.53
1.08
1.08
0.64
1.2
0.04
Diluted Earnings per share
1.31
0.53
1.08
1.08
0.64
1.2
0.04
Operating Profit Margin (Excl OI)
32.74%
29.05%
31.46%
31.56%
33.56%
31.43%
20.51%
Gross Profit Margin
33.51%
20.01%
33.87%
25.48%
22.84%
35.7%
16.56%
PAT Margin
23.3%
8.69%
18.01%
18.01%
10.68%
21.93%
0.58%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -8.10% vs 2.29% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 146.59% vs -50.52% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -6.26% vs -4.25% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -4.86% vs -10.00% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Bristol Myers Squibb Co. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
11,489.00
14,451.00
-2,962.00
-20.50%
Other Operating Income
0.00
0.00
0.00
Total Operating income
11,489.00
14,451.00
-2,962.00
-20.50%
Raw Material Cost
3,873.00
4,817.00
-944.00
-19.60%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
411.00
668.00
-257.00
-38.47%
Selling and Distribution Expenses
1,617.00
2,931.00
-1,314.00
-44.83%
Other Expenses
182.70
178.40
4.30
2.41%
Total Expenditure (Excl Depreciation)
7,728.00
10,200.00
-2,472.00
-24.24%
Operating Profit (PBDIT) excl Other Income
3,761.00
4,251.00
-490.00
-11.53%
Other Income
357.00
-7.00
364.00
5,200.00%
Operating Profit (PBDIT)
4,729.00
5,857.00
-1,128.00
-19.26%
Interest
411.00
668.00
-257.00
-38.47%
Exceptional Items
-468.00
-404.00
-64.00
-15.84%
Gross Profit (PBDT)
7,616.00
9,634.00
-2,018.00
-20.95%
Depreciation
611.00
1,613.00
-1,002.00
-62.12%
Profit Before Tax
3,239.00
3,170.00
69.00
2.18%
Tax
561.00
461.00
100.00
21.69%
Provisions and contingencies
0
0
0.00
Profit After Tax
2,677.00
2,700.00
-23.00
-0.85%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
2,677.00
2,700.00
-23.00
-0.85%
Share in Profit of Associates
0
0
0.00
Minority Interest
1.00
9.00
-8.00
-88.89%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,678.00
2,709.00
-31.00
-1.14%
Equity Capital
0
0
0.00
Face Value
0.10
0.05
0.00
Reserves
20,068.00
90,101.00
-70,033.00
-77.73%
Earnings per share (EPS)
1.31
0.47
0.84
178.72%
Diluted Earnings per share
1.31
0.47
0.84
178.72%
Operating Profit Margin (Excl OI)
32.74%
29.42%
0.00
3.32%
Gross Profit Margin
33.51%
33.10%
0.00
0.41%
PAT Margin
23.30%
18.68%
0.00
4.62%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,148.90 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -8.10% vs 2.29% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 2.57% vs -5.60% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 267.80 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 146.59% vs -50.52% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 8.77% vs 120.68% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 437.20 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -6.26% vs -4.25% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -3.89% vs 11.22% in Mar 2025

Quarterly - Interest
Interest 41.10 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -4.86% vs -10.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -16.80% vs 16.24% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 32.74%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025